Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    Amitriptyline in the Prevention of Childhood Migraine
Previous Study | Return to List | Next Study

The Childhood and Adolescent Migraine Prevention Study (CHAMP)

This study has been terminated.
(Interim assessment provided sufficient data to answer study questions)
Sponsor:
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier:
NCT01581281
First received: December 16, 2011
Last updated: September 21, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2016
  Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):